This systematic review synthesizes evidence from 29 studies spanning 2004 to 2024, elucidating the expression patterns, genetic/epigenetic alterations, prognostic implications, and mechanistic roles of SP100 family proteins across 25 cancer types. This evidence concerns the gene SP100 and cancer.